Wright Medical Group, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference

  Wright Medical Group, Inc. to Present at the 24th Annual Piper Jaffray
  Healthcare Conference

            Tuesday, November 27, 2012, at 10:30 a.m. Eastern Time

Piper Jaffray Healthcare Conference 2012

Business Wire

ARLINGTON, Tenn. -- November 13, 2012

Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device
company, announced today that it will be participating in the Piper Jaffray
Healthcare Conference on Tuesday, November 27, 2012, at the New York Palace
Hotel in New York, New York. Robert Palmisano, President and Chief Executive
Officer, will present at 10:30 a.m. Eastern Time.

A live audio webcast of the conference presentation, along with the
accompanying presentation materials, will be available on Wright’s corporate
website at www.wmt.com/corporate, under the “Investor Info” link. The audio
webcast and accompanying presentation materials will be archived on this site
under the “Investor Presentations” link following the conference.

About Wright Medical

Wright Medical Group, Inc. is a global orthopaedic medical device company and
a leading provider of surgical solutions for the foot and ankle market. The
Company specializes in the design, manufacture and marketing of devices and
biologic products for extremity, hip and knee repair and reconstruction. The
Company has been in business for more than 60 years and markets its products
in over 60 countries worldwide. For more information about Wright Medical,
visit the Company’s website at www.wmt.com.


This press release may contain “forward-looking statements” as defined under
U.S. federal securities laws. These statements reflect management's current
knowledge, assumptions, beliefs, estimates, and expectations and express
management's current view of future performance, results, and trends. Forward
looking statements may be identified by their use of terms such as anticipate,
believe, could, estimate, expect, intend, may, plan, predict, project, will,
and other similar terms. Forward-looking statements are subject to a number of
risks and uncertainties that could cause actual results to materially differ
from those described in the forward-looking statements. The reader should not
place undue reliance on forward-looking statements. Such statements are made
as of the date of this press release, and we undertake no obligation to update
such statements after this date. Risks and uncertainties that could cause our
actual results to materially differ from those described in forward-looking
statements are discussed in our filings with the Securities and Exchange
Commission (including those described in Item 1A of our Annual Report on Form
10-K for the year ended December 31, 2011 and our Quarterly Report on Form
10-Q for the quarter ended September 30, 2012, in each case under the heading
“Risk Factors” and elsewhere in such filings). By way of example and without
implied limitation, such risks and uncertainties include: future actions of
the United States Attorney’s office, the FDA, the Department of Health and
Human Services or other U.S. or foreign government authorities that could
delay, limit or suspend our development, manufacturing, commercialization and
sale of products, or result in seizures, injunctions, monetary sanctions or
criminal or civil liabilities; any actual or alleged breach of the Corporate
Integrity Agreement to which we are subject through September 2015 which could
expose us to significant liability including exclusion from Medicare, Medicaid
and other federal healthcare programs, potential criminal prosecution, and
civil and criminal fines or penalties; adverse outcomes in existing product
liability litigation; new product liability claims; inadequate insurance
coverage; the possibility of private securities litigation or shareholder
derivative suits; demand for and market acceptance of our new and existing
products; potentially burdensome tax measures; lack of suitable business
development opportunities; product quality or patient safety issues;
challenges to our intellectual property rights; geographic and product mix
impact on our sales; our inability to retain key sales representatives,
independent distributors and other personnel or to attract new talent;
inventory reductions or fluctuations in buying patterns by wholesalers or
distributors; inability to realize the anticipated benefits of restructuring
initiatives; negative impact of the commercial and credit environment on us,
our customers and our suppliers; and the potentially negative effect of our
ongoing compliance enhancements on our relationships with customers, and on
our ability to deliver timely and effective medical education, clinical
studies, and new products.


Wright Medical Group, Inc.
Julie D. Tracy, 901-290-5817
Sr. Vice President, Chief Communications Officer
Press spacebar to pause and continue. Press esc to stop.